Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,804 | 90 | 99.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15.72 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,749 | 15 | $0 (2024) |
| AbbVie Inc. | $1,692 | 15 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,471 | 13 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $674.18 | 7 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $611.62 | 6 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $579.27 | 6 | $0 (2018) |
| Amgen Inc. | $570.56 | 5 | $0 (2022) |
| ITI, Inc. | $489.62 | 4 | $0 (2023) |
| Aralez Pharmaceuticals US Inc. | $250.00 | 2 | $0 (2017) |
| Novo Nordisk Inc | $247.84 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $500.00 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($250.00) |
| 2023 | $479.24 | 4 | ITI, Inc. ($364.62) |
| 2022 | $721.98 | 6 | Amgen Inc. ($250.00) |
| 2021 | $582.57 | 5 | AbbVie Inc. ($232.33) |
| 2020 | $142.48 | 4 | Lilly USA, LLC ($125.12) |
| 2019 | $1,357 | 12 | AbbVie, Inc. ($465.62) |
| 2018 | $2,389 | 22 | AbbVie, Inc. ($536.52) |
| 2017 | $3,647 | 34 | AstraZeneca Pharmaceuticals LP ($769.23) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 05/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 04/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 12/06/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/09/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $114.62 | General |
| Category: DIABETES | ||||||
| 09/14/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $122.72 | General |
| Category: PSYCHIATRY | ||||||
| 03/16/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $116.90 | General |
| Category: PSYCHIATRY | ||||||
| 12/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $96.98 | General |
| Category: DIABETES | ||||||
| 09/22/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/14/2022 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Bone Health | ||||||
| 07/07/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 05/03/2022 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Bone Health | ||||||
| 01/27/2022 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Antibiotic | ||||||
| 07/28/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/15/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $107.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/06/2021 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Bone Health | ||||||
| 04/29/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $100.25 | General |
| Category: Gastroenterology | ||||||
| 04/14/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 10/23/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Diabetes | ||||||
| 02/13/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $96.99 | General |
| 02/13/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $19.40 | General |
| 02/13/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $8.73 | General |
| 11/14/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $124.08 | General |
| 11/12/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $121.88 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 247 | 458 | $70,315 | $20,243 |
| 2022 | 8 | 277 | 405 | $80,223 | $24,266 |
| 2021 | 9 | 316 | 483 | $81,370 | $24,783 |
| 2020 | 11 | 363 | 468 | $71,200 | $20,182 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 152 | $54,568 | $14,092 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $9,433 | $3,856 | 40.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 82 | 228 | $3,249 | $833.36 | 25.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,923 | $791.23 | 41.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $932.10 | $464.49 | 49.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 28 | $210.00 | $205.80 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 149 | $56,632 | $15,034 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $12,761 | $5,209 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 15 | $4,030 | $1,394 | 34.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 18 | 18 | $2,937 | $1,230 | 41.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $1,434 | $709.92 | 49.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 43 | 96 | $1,469 | $373.81 | 25.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 49 | 63 | $472.50 | $186.48 | 39.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $488.40 | $129.31 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 152 | $57,772 | $15,243 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 33 | 33 | $12,761 | $5,341 | 41.9% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 47 | 47 | $1,990 | $952.27 | 47.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $2,955 | $879.01 | 29.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 11 | 11 | $917.73 | $717.86 | 78.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2021 | 11 | 17 | $1,325 | $558.45 | 42.2% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 54 | 124 | $1,897 | $530.43 | 28.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 17 | 17 | $1,219 | $348.16 | 28.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 51 | 71 | $532.50 | $213.00 | 40.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 84 | 141 | $44,356 | $10,344 | 23.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 34 | 34 | $11,614 | $4,719 | 40.6% |
About Dr. Maya Rayzman, MD
Dr. Maya Rayzman, MD is a Internal Medicine healthcare provider based in Jamaica, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952356107.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maya Rayzman, MD has received a total of $9,820 in payments from pharmaceutical and medical device companies, with $500.00 received in 2024. These payments were reported across 91 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($9,804).
As a Medicare-enrolled provider, Rayzman has provided services to 1,203 Medicare beneficiaries, totaling 1,814 services with total Medicare billing of $89,474. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Jamaica, NY
- Active Since 05/24/2006
- Last Updated 09/26/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1952356107
Products in Payments
- JARDIANCE (Drug) $1,652
- FARXIGA (Drug) $984.53
- CAPLYTA (Drug) $614.62
- Synthroid (Drug) $556.05
- LINZESS (Drug) $482.32
- JANUVIA (Drug) $476.83
- Mavyret (Drug) $436.51
- TOUJEO (Drug) $414.18
- XARELTO (Drug) $312.57
- INVOKANA (Drug) $299.05
- EVENITY (Biological) $250.00
- Prolia (Biological) $250.00
- ZONTIVITY (Drug) $250.00
- BREZTRI (Drug) $249.99
- SOLIQUA (Drug) $165.09
- Ozempic (Drug) $139.24
- BEVESPI AEROSPHERE (Drug) $125.00
- ELIQUIS (Drug) $125.00
- REXULTI (Drug) $125.00
- Talicia (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jamaica
Robert Pyo, Md, MD
Internal Medicine — Payments: $63,065
Dr. Vincent Rizzo, M.d, M.D
Internal Medicine — Payments: $16,577
Dr. Parmeshwar Mahabir, Md, MD
Internal Medicine — Payments: $13,512
Osafradu Opam
Internal Medicine — Payments: $10,675
Danuta Kurstein, Md, MD
Internal Medicine — Payments: $9,953
James Ho, Md, MD
Internal Medicine — Payments: $8,188